Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Clinical trial NCT05620771 · RECRUITING
Trial details
- NCT number
- NCT05620771
- Sponsor
- Northwestern University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2040-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.